SGO Late Breaking: ESMO 2024
Developed by the SGO Education Committee, this resource is one of several downloadable PDFs which summarize takeaways from recent trials presented at key meetings, the newest FDA approvals, and more.
This PDF summarizes the latest from ESMO 2024, to include PRIMA/ENGOT-OV/GOG-3012 final analysis.
Target Audience
SGO Members

Facebook
X
LinkedIn
Forward